Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0503AN02 GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1295.81 C64H117N3O23
LMSP0503AJ05 Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1500.93 C74H136N2O28
LMSP0503AJ08 Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1526.94 C76H138N2O28
LMSP0503AI07 Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1482.92 C74H134N2O27
LMSP0503AI08 Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1510.95 C76H138N2O27
LMSP0503AC03 GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1485.89 C72H131N3O28
LMSP0503AD05 Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1704.01 C82H149N3O33
LMSP0503AD06 Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1732.04 C84H153N3O33
LMSP0503AD02 Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1619.91 C76H137N3O33
LMSP0503AN08 GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1405.92 C72H131N3O23
LMSP0503AO03 GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1485.89 C72H131N3O28
LMSP0503AD08 Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1730.02 C84H151N3O33
LMSP0503AL07 GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1848.05 C88H157N3O37
LMSP0503AN06 GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1407.93 C72H133N3O23
LMSP0503AM02 GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1619.91 C76H137N3O33
LMSP0503AJ06 Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1528.96 C76H140N2O28
LMSP0503AK03 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1590.92 C76H138N2O32
LMSP0503AE01 GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1429.83 C68H123N3O28
LMSP0503AL03 GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1794 C84H151N3O37
LMSP0503AL05 GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1850.07 C88H159N3O37
LMSP0503AM08 GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1730.02 C84H151N3O33
LMSP0503AK02 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1562.89 C74H134N2O32
LMSP0503AH04 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1822.03 C86H155N3O37
LMSP0503AF02 Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1619.91 C76H137N3O33
LMSP0503AI04 Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1456.9 C72H132N2O27
LMSP0503AD07 Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1701.99 C82H147N3O33
LMSP0503AM07 GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1701.99 C82H147N3O33
LMSP0503AH05 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1850.07 C88H159N3O37
LMSP0503AH06 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1878.1 C90H163N3O37
LMSP0503AN01 GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1267.78 C62H113N3O23
LMSP0503AE04 GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1513.92 C74H135N3O28
LMSP0503AN07 GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1377.89 C70H127N3O23
LMSP0503AI03 Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1428.87 C70H128N2O27
LMSP0503AL04 GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1822.03 C86H155N3O37
LMSP0503AK07 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1644.97 C80H144N2O32
LMSP0503AF01 Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1591.88 C74H133N3O33
LMSP0503AH03 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1794 C84H151N3O37
LMSP0503AK08 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1673 C82H148N2O32
LMSP0503AK05 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1646.99 C80H146N2O32
LMSP0503AF04 Galbeta1-4GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1675.98 C80H145N3O33
LMSP0503AC01 GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1429.83 C68H123N3O28
LMSP0503AH02 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1765.97 C82H147N3O37
LMSP0503AC08 GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1567.97 C78H141N3O28
LMSP0503AC04 GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1513.92 C74H135N3O28
LMSP0503AJ04 Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1472.9 C72H132N2O28
LMSP0503AG08 Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1714.03 C84H151N3O32
LMSP0503AH08 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1876.08 C90H161N3O37
LMSP0503AK04 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1618.95 C78H142N2O32
LMSP0503AO06 GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1569.99 C78H143N3O28
LMSP0503AH07 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1848.05 C88H157N3O37